Modular 18F Prosthetic Groups for Protein Labeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for labeling proteins with 18F-based prosthetic groups are hindered by long synthesis times, poor radiochemical yields, and low specific activity, making it difficult to develop effective PET imaging agents for molecular imaging and therapeutic applications.
Innovation Solution
A modular platform for rapidly preparing water-soluble prosthetic groups, such as [18F]FPEGMA, which efficiently introduces 18F into proteins through site-specific conjugation, utilizing polyethylene glycol (PEG) based building blocks and the CuAAC reaction for high-yield and high-purity labeling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional 18F-based prosthetic groups are used for protein labeling, then radioactivity can be introduced into proteins, but the synthesis time is long and radiochemical yield is poor
Solution Approach 1:
The prosthetic group is divided into modular components (fluoride, PEG chain, maleimide) that can be assembled through sequential reactions. The CuAAC click chemistry enables modular assembly of the fluorinated PEG unit onto the maleimide-containing protein, allowing efficient one-pot conjugation that dramatically reduces synthesis time compared to conventional multi-step labeling protocols.
Solution Approach 2:
The invention changes the chemical parameters of the labeling reaction by using CuAAC click chemistry instead of conventional nucleophilic substitution. This parameter change enables the reaction to proceed under milder conditions with higher efficiency, achieving rapid conjugation at room temperature or physiological conditions, thereby reducing synthesis time and improving radiochemical yield.
2Quantity of substance
If conventional labeling methods are used, then proteins can be labeled with 18F, but specific activity is low
Solution Approach 1:
The invention introduces site-specific labeling by incorporating a single cysteine residue at a predetermined position on the protein (away from the binding site). This local modification ensures that the 18F label is attached at a specific location, enabling high specific activity while preserving the protein's biological function and binding activity.
Solution Approach 2:
The maleimide group serves as an intermediary that facilitates the attachment of the 18F-labeled PEG prosthetic group to the cysteine thiol on the protein. This intermediary approach enables efficient and specific conjugation, achieving high specific activity through controlled single-site labeling rather than random modification.
3Reliability
If site-specific conjugation is performed, then biological activity is retained, but the process requires precise control of modification sites
Solution Approach 1:
The protein is pre-engineered with a specific cysteine residue at a predetermined position (using PHESELECTOR methodology) before the labeling reaction. This preliminary genetic modification ensures that the subsequent chemical conjugation occurs at a single, controlled site that does not interfere with the protein's binding function, thereby simplifying the conjugation control while ensuring biological activity retention.
Solution Approach 2:
The invention uses genetically engineered proteins with incorporated cysteine residues as templates for site-specific labeling. By creating a copy or variant of the native protein with a strategically placed cysteine, the labeling process can be controlled at a specific site that mimics the native structure's functional requirements, ensuring both precision and biological activity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the rapid production of 18F-labeled proteins with improved conjugation efficiency and specific activity, retaining biological activity and facilitating effective molecular imaging and therapeutic applications.
Implementation Method 1
utilizing polyethylene glycol (PEG) based building blocks and the CuAAC reaction for high-yield and high-purity labeling
Data Source
Figure 1~2
Figure 3~4
Figure 5(a)~5(b)
AI summary
A modular platform is provided for rapid preparation of various water-soluble prosthetic groups capable to efficiently introduce 18F into proteins with 18F labelling reagents.